Patient training in medicines R&D
EUPATI offers patients and patient advocates expert-level training in medical research and development. EUPATI RELOAD aims to increase both its effectiveness and reach.
The EUPATI Patient Expert Training Course mixes online and in-person training over a 14-month period to give patients and patient advocates advanced knowledge of the research and development pathway for medicines.The goal is to increase the level of knowledge in the patient community not just in Europe but around the world.
EUPATI RELOAD aims to adapt the current training to cater for each learner’s needs, making the course more accessible and sustainable.
A key step is to repackage the existing six modules into up to 30 shorter modules, which means they can be offered in a format similar to the popular Massive Open Online Courses (MOOCs) found on learning platforms such as Coursera. Another improvement will be to enhance the e-learning elements of the face-to-face programme by using experiential and problem-based learning.
External partner
Partners
CLC/InnoStars: Scandinavia
Partner classification: Education, Research
Partner type: Core Partner
With over 40,000 students and more than 9,500 employees, UCPH – founded 1479 – is among the largest comprehensive universities in Europe. It is ranked No. 7 in Europe and no. 39 in the world in the Academic Ranking of World Universities 2015. The University has an international environment where ambitious researchers and students strive for new knowledge and insights. UCPH is placed at the centre of a stimulation entrepreneurial ecosystem in the Greater Copenhagen Area.
University of Copenhagen (UCPH)
University of Copenhagen (UCPH), Universitetsparken 1, 2100 København Ø, Denmark
Key Activities in Corporate Innovation
Pharma, Med Tech, ICT, Diagnostics, Imaging, Nutrition
Key Activities in Social Innovation
Healthcare provision
Key Activities in Business Creation
Testing & Validation
Key Activities in Education
Entrepreneurship training, Medical faculties, Healthcare professional education/training
CLC/InnoStars: Germany
Partner classification: Business
Partner type: Associate Partner
Bayer Pharma is the pharmaceutical division of Bayer AG. Their products improve people’s quality of life worldwide generating sales of more than 12 billion Euros. Their R&D efforts are focused on Cardiology, Oncology, Ophthalmology, Hematology and Gynecology.
Key Activities in Research and Developement
Biomedical engineering, Life Sciences, Clinical research
Key Activities in Corporate Innovation
Pharma, Diagnostics
Key Activities in Social Innovation
Healthcare provision
Key Activities in Business Creation
Incubation, Finance & Investment, Business coaching
Key Activities in Education
Entrepreneurship training, Healthcare professional education/training